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Age-related hearing loss Presbycusis Chronic inflammation Inflammaging Aging cochlea Aging inner ear A B S T R A C T Chronic, low-grade inflammation, or inflammaging, is a crucial contributor to various age-related pathologies and natural processes in aging tissue, including the nervous system. Over the past two decades, much effort has been done to understand the mechanisms of inflammaging in disease models such as type II diabetes, cardiovascular disease, Alzheimer's disease, Parkinson's disease, and others. However, despite being the most prevalent neurodegenerative disorder, the number one communication disorder, and one of the top three chronic medical conditions of our aged population; little research has been conducted on the potential role of inflammation in age-related hearing loss (ARHL). Recently, it has been suggested that there is an inflammatory presence in the cochlea, perhaps involving diffusion processes of the blood-brain barrier as it relates to the inner ear. Recent research has found correlations between hearing loss and markers such as C-reactive protein, IL-6, and TNF-α indicating inflammatory status in human case-cohort studies. However, there have been very few reports of in vivo research investigating the role of chronic inflammation's in hearing loss in the aging cochlea. Future research directed at better understanding the mechanisms of inflammation in the cochlea as well as the natural changes acquired with aging may provide a better understanding of how this process can accelerate presbycusis. Animal model experimentation and pre-clinical studies designed to recognize and characterize cochlear inflammatory mechanisms may suggest novel treatment strategies for preventing or treating ARHL. In this review, we seek to summarize key research in chronic inflammation, discuss its implications for possible roles in ARHL, and finally suggest directions for future investigations.
Introduction
Age-related hearing loss (ARHL) or presbycusis is one of the most prevalent conditions among elderly individuals. Currently, about 10 percent of the world's population is affected by ARHL which correlates to about 30 million people in the US alone. Consequently, these individuals generally have trouble communicating with family members and co-workers, have declines in quality of life, and can suffer from depression, especially when their hearing impairment is accompanied by tinnitus-ringing of the ears (Dalton et al., 2003) . Current research suggests that presbycusis is a multifactorial condition with multiple pathways and underlying conditions contributing to the biological mechanisms (Gates and Mills, 2005) . Unlike other medical disorders with similar prevalence, ARHL lacks any biomedical treatment or preventative measures that materially reduce risk. Because of the dynamic nature of the condition, the full mechanisms of its actions are still being investigated.
In recent years, inflammation has been a key area of interest in biomedical research investigations of age-related conditions. As tissue ages, the body experiences a phenomenon known as "chronic inflammation." Chronic inflammation also referred to as "inflammaging" is a mild form of inflammation that worsens with age. This inflammaging process is the phenomenon of immunosenescence, including the normal fluctuations resulting from an aging immune system (Gruver et al., 2007) . This age-dependent immunosenescence process ultimately results in the body becoming increasingly worse at controlling or downregulating the production of pro-inflammatory proteins during and after immune responses (Capri et al., 2006) . Consequently, a progressively higher inflammatory state is observed in many aging tissues (Verschuur et al., 2014; Fulop et al., 2016) . However, the potential
